Individual risk assessment for prostate cancer: an impact analysis.

Individual risk assessment for prostate cancer: an impact analysis. - IMPACT

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON35373

Enrollment

650

Registered

2008-09-18

Start date

2008-10-15

Completion date

Unknown

Last updated

2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

prostate cancer Prostate carcinoma

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: * Men between 55 and 75 years old * Confronted with the option of undergoing a diagnostic prostate biopsy or wanting to be screened for prostate cancer * Signed informed consent

Exclusion criteria

Exclusion criteria: History of prostate cancer

Design outcomes

Primary

Measure	Time frame
Primary endpoints are adherence, compliance and impact on the patient.	—

Secondary

Measure	Time frame
Alongside the implementation process, the data available on the number of biopsies and referral to active surveillance before and after implementation of the Prostaatwijzer ®, as well as costs, will be compared.	—

Countries

Netherlands

Outcome results